Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Cardiorenal Effects of Chronic Phosphodiesterase-V Inhibition in Preclinical Diastolic Dysfunction (Stage B Heart Failure)

Journal of Cardiac Failure(2023)10.1016/j.cardfail.2023.05.019Source: DataRank Database

The Cardiorenal Effects of Chronic Phosphodiesterase-V Inhibition in Preclinical Diastolic Dysfunction (Stage B Heart Failure) is a research paper published in Journal of Cardiac Failure (2023). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access0 citations

Download PDF

Cite:

Linked data & code

nct

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT02058095

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: greenTopics (19)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Fadi Adel ORCID,Paul M. McKie ORCID,Christopher G. Scott ORCID,Horng H. Chen ORCID,Shravya Vinnakota ORCID

Live enrichment

PubMed:37295665 PMC:PMC10592474

NHLBI NIH HHS

Grant: P01 HL076611

NHLBI NIH HHS

Grant: R01 HL136440

NHLBI NIH HHS

Grant: R01 HL084155

NCRR NIH HHS

Grant: UL1 RR024150

NIH

NHLBI

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10592474/pdf/nihms-1912416.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1071916423001963?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1071916423001963?httpAccept=text/plain

MeSH Terms

HumansCyclic GMPGlomerular Filtration RateTreatment OutcomeDouble-Blind MethodDiastoleAgedMiddle AgedFemaleMaleHeart FailureHeart Failure, DiastolicPhosphodiesterase 5 InhibitorsTadalafilProof of Concept Study

Keywords

cGMPTadalafilHeart Failure With Preserved Ejection FractionPde V Inhibition

The Cardiorenal Effects of Chronic Phosphodiesterase-V Inhibition in Preclinical Diastolic Dysfunction (Stage B Heart Failure)

FAIR Checklist

Authors (5)

Funding (6 grants)

Open Access

Topics

Annotations (Europe PMC)